Download PDF
J Neurol Surg B Skull Base 2021; 82(02): 208-215
DOI: 10.1055/s-0039-1697036
Original Article

Trends in the Management Paradigms of Intracranial Meningioma

Zaid Aljuboori 
1   Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky, United States
,
Ahmad Alhourani
1   Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky, United States
,
Shiao Woo
2   Department of Radiation Oncology, University of Louisville School of Medicine, Louisville, Kentucky, United States
,
Eyas Hattab
3   Department of Pathology, University of Louisville School of Medicine, Louisville, Kentucky, United States
,
Mehran Yusuf
2   Department of Radiation Oncology, University of Louisville School of Medicine, Louisville, Kentucky, United States
,
Megan Nelson
4   Division of Physical and Medical Rehabilitation, Department of Neurological surgery, University of Louisville School of Medicine, Louisville, Kentucky, United States
,
Norberto Andaluz
1   Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky, United States
,
Dale Ding
1   Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky, United States
,
Jesse Savage
5   Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, Indiana, United States
,
Brian Williams
1   Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky, United States
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective Intracranial meningiomas are the most common primary brain tumor. Treatment paradigms have evolved over time. There are limited number of population-based studies that examine this modern evolution. Here, we describe the trends of management of intracranial meningiomas using a national database.

Methods The data were obtained from the National Cancer Database for the years 2004 to 2015, the collected variables included: patients' age, gender, insurance type, income, comorbidity score, the tumor size and grade, and treatment modality (observation, surgery, radiotherapy, or combination therapy). We performed statistical analyses to detect association between unique variables and outcomes. In addition, we performed mortality analyses for various treatment modalities.

Results A total of 199,096 patients with a diagnosis of intracranial meningioma were included, the majority of patients were white females, mean age of 61 years, and half of the tumors were ≤ 3 cm. Observation was the most commonly used management modality followed by surgical resection, radiotherapy, and combination therapy. For the entire time period, there was an increased use of observation as a primary management method. Predictors of mortality included increased age, larger tumor size, higher tumor grade, treatment at a community hospital, and higher comorbidity scores.

Conclusion Population-based studies of intracranial meningiomas are uncommon; our study is one of the few reports that examine the changes in the modern management paradigms of meningioma in the United States over time. Additionally, we shed light on the factors that affected survival of patients with this condition.

Keywords

brain tumor - meningioma - surgery - radiotherapy - observation - database

Disclosure

Brian J. Williams is a consultant at Monteris Medical.




Publication History

Received: 22 March 2019

Accepted: 11 August 2019

Article published online:
17 September 2019

© 2019. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 1996; 29 (03) 197-205
    CrossrefPubMedGoogle Scholar
  • 2 Pendleton C, Olivi A, Brem H, Quiñones-Hinojosa A. Harvey Cushing's early treatment of meningiomas: the untold story. World Neurosurg 2013; 80 (1-2): 217-221
    CrossrefPubMedGoogle Scholar
  • 3 Arora RS, Alston RD, Eden TO. et al. Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003. Eur J Cancer 2010; 46 (09) 1607-1616
    CrossrefPubMedGoogle Scholar
  • 4 Gigineishvili D, Gigineishvili T, Tsiskaridze A, Shakarishvili R. Incidence rates of the primary brain tumours in Georgia--a population-based study. BMC Neurol 2014; 14: 29
    CrossrefPubMedGoogle Scholar
  • 5 Ostrom QT, Gittleman H, Liao P. et al. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro-oncol 2017; 19 (05) (Suppl. 05) v1-v88
    CrossrefPubMedGoogle Scholar
  • 6 Solheim O, Torsteinsen M, Johannesen TB, Jakola AS. Effects of cerebral magnetic resonance imaging in outpatients on observed incidence of intracranial tumors and patient survival: a national observational study. J Neurosurg 2014; 120 (04) 827-832
    CrossrefPubMedGoogle Scholar
  • 7 Di Maio S, Ramanathan D, Garcia-Lopez R. et al. Evolution and future of skull base surgery: the paradigm of skull base meningiomas. World Neurosurg 2012; 78 (3-4): 260-275
    CrossrefPubMedGoogle Scholar
  • 8 Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV. An overview of meningiomas. Future Oncol 2018; 14 (21) 2161-2177
    CrossrefPubMedGoogle Scholar
  • 9 Fuentes-Raspall R, Vilardell L, Perez-Bueno F. et al. Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain) 1994-2005. J Neurooncol 2011; 101 (01) 117-123
    CrossrefPubMedGoogle Scholar
  • 10 Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008; 15 (03) 683-690
    CrossrefPubMedGoogle Scholar
  • 11 Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45 (06) 613-619
    CrossrefPubMedGoogle Scholar
  • 12 de Haan R, Aaronson N, Limburg M, Hewer RL, van Crevel H. Measuring quality of life in stroke. Stroke 1993; 24 (02) 320-327
    CrossrefPubMedGoogle Scholar
  • 13 Agarwal V, McCutcheon BA, Hughes JD. et al. Trends in management of intracranial meningiomas: analysis of 49,921 cases from modern cohort. World Neurosurg 2017; 106: 145-151
    CrossrefPubMedGoogle Scholar
  • 14 Chamoun R, Krisht KM, Couldwell WT. Incidental meningiomas. Neurosurg Focus 2011; 31 (06) E19
    CrossrefPubMedGoogle Scholar
  • 15 Jadid KD, Feychting M, Höijer J, Hylin S, Kihlström L, Mathiesen T. Long-term follow-up of incidentally discovered meningiomas. Acta Neurochir (Wien) 2015; 157 (02) 225-230 , discussion 230
    CrossrefPubMedGoogle Scholar
  • 16 Kuratsu J, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 2000; 92 (05) 766-770
    CrossrefPubMedGoogle Scholar
  • 17 Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J. Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 2000; 68 (01) 25-28
    CrossrefPubMedGoogle Scholar
  • 18 Radhakrishnan K, Mokri B, Parisi JE, O'Fallon WM, Sunku J, Kurland LT. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 1995; 37 (01) 67-73
    CrossrefPubMedGoogle Scholar
  • 19 Ambekar S, Sharma M, Madhugiri VS, Nanda A. Trends in intracranial meningioma surgery and outcome: a Nationwide Inpatient Sample database analysis from 2001 to 2010. J Neurooncol 2013; 114 (03) 299-307
    CrossrefPubMedGoogle Scholar
  • 20 Barker II FG, Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS. In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the effect of hospital and surgeon volume. Neurosurgery 2003; 52 (05) 995-1007 , discussion 1007–1009
    PubMedGoogle Scholar
  • 21 Cowan Jr JA, Dimick JB, Leveque JC, Thompson BG, Upchurch Jr GR, Hoff JT. The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery 2003; 52 (01) 48-53 , discussion 53–54
    PubMedGoogle Scholar
  • 22 Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL. Epidemiology of meningiomas post-Public Law 107-206: the Benign Brain Tumor Cancer Registries Amendment Act. Cancer 2015; 121 (14) 2400-2410
    CrossrefPubMedGoogle Scholar
  • 23 Cao X, Hao S, Wu Z. et al. Survival rates, prognostic factors and treatment of anaplastic meningiomas. J Clin Neurosci 2015; 22 (05) 828-833
    CrossrefPubMedGoogle Scholar
  • 24 Kumar N, Kumar R, Khosla D, Salunke PS, Gupta SK, Radotra BD. Survival and failure patterns in atypical and anaplastic meningiomas: a single-center experience of surgery and postoperative radiotherapy. J Cancer Res Ther 2015; 11 (04) 735-739
    CrossrefPubMedGoogle Scholar
  • 25 Moliterno J, Cope WP, Vartanian ED. et al. Survival in patients treated for anaplastic meningioma. J Neurosurg 2015; 123 (01) 23-30
    CrossrefPubMedGoogle Scholar
  • 26 Celtikci E, Kaymaz AM, Akgul G, Karaaslan B, Emmez OH, Borcek A. Retrospective analysis of 449 intracranial meningioma patients operated between 2007 and 2013 at a single institute. Turk Neurosurg 2018; 28 (01) 1-6
    PubMedGoogle Scholar
  • 27 Curry WT, McDermott MW, Carter BS, Barker II FG. Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg 2005; 102 (06) 977-986
    CrossrefPubMedGoogle Scholar